Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways

Twenty 9<i>O</i>-substituted palmatine derivatives were prepared and tested for their biological effect against collagen &#945;1 (I) (COL1A1) promotor in human hepatic stellate LX-2 cells. The structure&#8722;activity relationship (SAR) indicated that the introduction of a benzyl...

Full description

Bibliographic Details
Main Authors: Tianyun Fan, Maoxu Ge, Zhihao Guo, Hongwei He, Na Zhang, Yinghong Li, Danqing Song
Format: Article
Language:English
Published: MDPI AG 2020-02-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/4/773
id doaj-ffd817eb7f704af29d7fabef2fcd93b6
record_format Article
spelling doaj-ffd817eb7f704af29d7fabef2fcd93b62020-11-25T02:03:23ZengMDPI AGMolecules1420-30492020-02-0125477310.3390/molecules25040773molecules25040773Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 PathwaysTianyun Fan0Maoxu Ge1Zhihao Guo2Hongwei He3Na Zhang4Yinghong Li5Danqing Song6Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaInstitute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, ChinaTwenty 9<i>O</i>-substituted palmatine derivatives were prepared and tested for their biological effect against collagen &#945;1 (I) (COL1A1) promotor in human hepatic stellate LX-2 cells. The structure&#8722;activity relationship (SAR) indicated that the introduction of a benzyl motif on the 9<i>O</i> atom was favorable for activity. Among them, compound <b>6c</b> provided the highest inhibitory effect against COL1A1 with an IC<sub>50</sub> value of 3.98 &#956;M, and it also dose-dependently inhibited the expression of fibrogenic COL1A1, &#945;-soomth muscle actin (&#945;-SMA), matrix metalloprotein 2 (MMP2) in both mRNA and protein levels, indicating extensive inhibitory activity against fibrogenesis. A further primary mechanism study indicated that it might repress the hepatic fibrogenesis via inhibiting both canonical transforming growth factor-beta 1 (TGF-&#946;1)/Smads and non-canonical janus-activated kinase 1 (JAK1)/singal transducer and activator of transcription 3 (STAT3) signaling pathways. Additionally, <b>6c</b> owned a high safety profile with the LD<sub>50</sub> value of over 1000 mg&#183;kg<sup>&#8722;1</sup> in mice. These results identified palmatine derivatives as a novel class of anti-fibrogenic agents, and provided powerful information for further structure optimization.https://www.mdpi.com/1420-3049/25/4/773hepatic fibrosispalmatinestructure−activity relationshipcol1a1tgf-β1/smads pathwayjak1/stat3 pathway
collection DOAJ
language English
format Article
sources DOAJ
author Tianyun Fan
Maoxu Ge
Zhihao Guo
Hongwei He
Na Zhang
Yinghong Li
Danqing Song
spellingShingle Tianyun Fan
Maoxu Ge
Zhihao Guo
Hongwei He
Na Zhang
Yinghong Li
Danqing Song
Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways
Molecules
hepatic fibrosis
palmatine
structure−activity relationship
col1a1
tgf-β1/smads pathway
jak1/stat3 pathway
author_facet Tianyun Fan
Maoxu Ge
Zhihao Guo
Hongwei He
Na Zhang
Yinghong Li
Danqing Song
author_sort Tianyun Fan
title Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways
title_short Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways
title_full Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways
title_fullStr Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways
title_full_unstemmed Discovery of 9<i>O</i>-Substituted Palmatine Derivatives as a New Class of Anti-COL1A1 Agents Via Repressing TGF-β1/Smads and JAK1/STAT3 Pathways
title_sort discovery of 9<i>o</i>-substituted palmatine derivatives as a new class of anti-col1a1 agents via repressing tgf-β1/smads and jak1/stat3 pathways
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2020-02-01
description Twenty 9<i>O</i>-substituted palmatine derivatives were prepared and tested for their biological effect against collagen &#945;1 (I) (COL1A1) promotor in human hepatic stellate LX-2 cells. The structure&#8722;activity relationship (SAR) indicated that the introduction of a benzyl motif on the 9<i>O</i> atom was favorable for activity. Among them, compound <b>6c</b> provided the highest inhibitory effect against COL1A1 with an IC<sub>50</sub> value of 3.98 &#956;M, and it also dose-dependently inhibited the expression of fibrogenic COL1A1, &#945;-soomth muscle actin (&#945;-SMA), matrix metalloprotein 2 (MMP2) in both mRNA and protein levels, indicating extensive inhibitory activity against fibrogenesis. A further primary mechanism study indicated that it might repress the hepatic fibrogenesis via inhibiting both canonical transforming growth factor-beta 1 (TGF-&#946;1)/Smads and non-canonical janus-activated kinase 1 (JAK1)/singal transducer and activator of transcription 3 (STAT3) signaling pathways. Additionally, <b>6c</b> owned a high safety profile with the LD<sub>50</sub> value of over 1000 mg&#183;kg<sup>&#8722;1</sup> in mice. These results identified palmatine derivatives as a novel class of anti-fibrogenic agents, and provided powerful information for further structure optimization.
topic hepatic fibrosis
palmatine
structure−activity relationship
col1a1
tgf-β1/smads pathway
jak1/stat3 pathway
url https://www.mdpi.com/1420-3049/25/4/773
work_keys_str_mv AT tianyunfan discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways
AT maoxuge discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways
AT zhihaoguo discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways
AT hongweihe discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways
AT nazhang discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways
AT yinghongli discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways
AT danqingsong discoveryof9ioisubstitutedpalmatinederivativesasanewclassofanticol1a1agentsviarepressingtgfb1smadsandjak1stat3pathways
_version_ 1724948668549693440